Mohan Mallikarjuna Rao Edupuganti, MD

Primary Patency With Stenting Versus Balloon Angioplasty for Arteriovenous Graft Failure: A Systematic Review and Meta-Analysis

11/23/2019

Mehmet Cilingiroglu , MD;

Konstantinos Dean Boudoulas , MD;

Ismail Dogu Kilic , MD;

Mohan Mallikarjuna Rao Edupuganti , MD;

Marwan Saad , MD, PhD, MS;

Akash Gupta ;

Nikolaos Lontos , MD;

Konstantinos Marmagkiolis , MD, MBA, FACC, FSCAI;

Abstract: Objectives. To evaluate the efficacy of advanced stent technology in the management of failing arteriovenous grafts (AVGs). Background. End-stage renal disease rates and the need for hemodialysis are increasing worldwide. AVG...

Abstract: Objectives. To...

11/23/2019

Journal of Invasive Cardiology

Original Contribution

Clinical Decision-Making for the Hemodynamic "Gray Zone" (FFR 0.75-0.80) and Long-Term Outcomes

04/15/2017

Shiv Kumar Agarwal , MD;

Srikanth R. Kasula , MD;

Sameer Raina , MD;

Fnu Shailesh , MD;

Jason J. Payne , MD;

Naga V. Pothineni , MD;

Abdul Hakeem , MD;

Barry F. Uretsky , MD;

Ahmed Almomani , MBBS, MD;

Mohan Mallikarjuna Rao Edupuganti , MD;

Fractional flow reserve (FFR) value between 0.75 and 0.80 is considered the "gray zone" and outcomes data relative to treatment strategy (revascularization vs medical therapy alone [deferral]) are limited for this group. A total of 238...

Fractional flow reserve (FFR)...

04/15/2017

Journal of Invasive Cardiology